金属对金属髋关节植入物中钴的耳毒性潜力:客观听觉与前庭功能结果
该前瞻性研究将20例初次金属对金属(MoM)髋关节假体植入患者按年龄、性别和噪声暴露与20名非植入对照者匹配,进行扩展听力学和前庭功能测试并检测血浆钴浓度。患者组高频听阈有升高趋势、DPOAE和TEOAE振幅有降低趋势、ABR波V耳间潜伏期差有增大趋势,前庭测试中cVEMP P1潜伏期延长、oVEMP振幅升高、vHIT增益不对称比降低;患者组血浆钴水平与听觉或前庭结果参数间未见提示性关联。
要点
- MoM髋植入患者高频听阈呈升高趋势,提示钴可能损伤高频听力。
- 患者组DPOAE与TEOAE振幅呈降低趋势,ABR波V耳间潜伏期差呈增大趋势。
- 患者组cVEMP P1潜伏期延长、oVEMP振幅升高、vHIT增益不对称比降低。
核心结论
- 听觉结果似乎反映高频听力功能存在钴所致损害的征象。
- 前庭结果尚不确定,需进一步阐明,尤其需结合动物研究。
- 缺乏明确的剂量-反应关系可能质疑结果的临床相关性,但近期MoM髋植入患者中的发现已证实该关系可受许多患者特异性因素影响。
研究设计与样本
- 前瞻性客观检查植入MoM髋假体患者的听觉与前庭功能。
- 20例初次MoM髋假体植入患者(15男5女,年龄33至65岁)按年龄、性别和噪声暴露与20名非植入对照者匹配。
- 每位参与者接受扩展听力学测试(常规与高频纯音测听、TEOAE与DPOAE、ABR)和前庭测试组合(cVEMP与oVEMP、旋转试验、冷热试验、vHIT),并采集血样测定血浆钴浓度。
主要发现
- 血浆钴浓度中位数[四分位距]在MoM患者组为1.40[0.70, 6.30]µg/L,在对照组为0.19[0.09, 0.34]µg/L。
- 听力学测试组合中,患者组较对照组呈现听阈(11.2至16 kHz)升高、DPOAE(4至8 kHz间)和总TEOAE(1至4 kHz)振幅降低、ABR波V耳间潜伏期差增大的明显趋势(0.01≤p<0.05)。
- 前庭测试组合中,MoM患者组cVEMP P1潜伏期明显延长、oVEMP振幅升高(0.01≤p<0.05)、vHIT增益不对称比降低(p<0.01)。
- 在患者组中,血浆钴水平与听觉或前庭结果参数间未见提示性关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 前庭结果尚不确定,需进一步阐明,尤其需结合动物研究。
- 缺乏明确的剂量-反应关系可能质疑结果的临床相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: During the past decade, the initial popularity of metal-on-metal (MoM) hip implants has shown a progressive decline due to increasingly reported implant failure and revision surgeries. Local as well as systemic toxic side effects have been associated with excessive metal ion release from implants, in which cobalt (Co) plays an important role. The rare condition of systemic cobaltism seems to manifest as a clinical syndrome with cardiac, endocrine, and neurological symptoms, including hearing loss, tinnitus, and imbalance. In most cases described in the literature, revision surgery and the subsequent drop in blood Co level led to (partial) alleviation of the symptoms, suggesting a causal relationship with Co exposure. Moreover, the ototoxic potential of Co has recently been demonstrated in animal experiments. Since its ototoxic potential in humans is merely based on anecdotal case reports, the current study aimed to prospectively and objectively examine the auditory and vestibular function in patients implanted with a MoM hip prosthesis. DESIGN: Twenty patients (15 males and 5 females, aged between 33 and 65 years) implanted with a primary MoM hip prosthesis were matched for age, gender, and noise exposure to 20 non-implanted control subjects. Each participant was subjected to an extensive auditory (conventional and high-frequency pure tone audiometry, transient evoked and distortion product otoacoustic emissions [TEOAEs and DPOAEs], auditory brainstem responses [ABR]) and vestibular test battery (cervical and ocular vestibular evoked myogenic potentials [cVEMPs and oVEMPs], rotatory test, caloric test, video head impulse test [vHIT]), supplemented with a blood sample collection to determine the plasma Co concentration. RESULTS: The median [interquartile range] plasma Co concentration was 1.40 [0.70, 6.30] µg/L in the MoM patient group and 0.19 [0.09, 0.34] µg/L in the control group. Within the auditory test battery, a clear trend was observed toward higher audiometric thresholds (11.2 to 16 kHz), lower DPOAE (between 4 and 8 kHz), and total TEOAE (1 to 4 kHz) amplitudes, and a higher interaural latency difference for wave V of the ABR in the patient versus control group (0.01 ≤ p < 0.05). Within the vestibular test battery, considerably longer cVEMP P1 latencies, higher oVEMP amplitudes (0.01 ≤ p < 0.05), and lower asymmetry ratio of the vHIT gain (p < 0.01) were found in the MoM patients. In the patient group, no suggestive association was observed between the plasma Co level and the auditory or vestibular outcome parameters. CONCLUSIONS: The auditory results seem to reflect signs of Co-induced damage to the hearing function in the high frequencies. This corresponds to previous findings on drug-induced ototoxicity and the recent animal experiments with Co, which identified the basal cochlear outer hair cells as primary targets and indicated that the cellular mechanisms underlying the toxicity might be similar. The vestibular outcomes of the current study are inconclusive and require further elaboration, especially with respect to animal studies. The lack of a clear dose-response relationship may question the clinical relevance of our results, but recent findings in MoM hip implant patients have confirmed that this relationship can be complicated by many patient-specific factors.
引用
- Leyssens L, Vinck B, Van Der Straeten C, et al. The Ototoxic Potential of Cobalt From Metal-on-Metal Hip Implants: Objective Auditory and Vestibular Outcome. Ear Hear. 2020. PMID: 31169566. doi:10.1097/AUD.0000000000000747
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。